OrthoPediatrics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orthopediatrics Corp (KIDS)
Orthopediatrics Corp stock price live, this page displays NASDAQ KIDS stock exchange data. View the KIDS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Orthopediatrics Corp real time stock price chart below.
What Is the Orthopediatrics Corp Stock Price Today?
The Orthopediatrics Corp stock price today is 15.20.
What Is the Stock Symbol for Orthopediatrics Corp?
The stock symbol for Orthopediatrics Corp is "KIDS."
What Stock Exchange Does Orthopediatrics Corp Trade On?
Orthopediatrics Corp is listed and trades on the NASDAQ stock exchange.
Is Orthopediatrics Corp a Good Stock to Buy?
Determining whether Orthopediatrics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KIDS quote. (ISIN: US68752L1008)
What Is the Orthopediatrics Corp Stock Price Today?
The Orthopediatrics Corp stock price today is 15.20.
What Is the Stock Symbol for Orthopediatrics Corp?
The stock symbol for Orthopediatrics Corp is "KIDS."
What Stock Exchange Does Orthopediatrics Corp Trade On?
Orthopediatrics Corp is listed and trades on the NASDAQ stock exchange.
Is Orthopediatrics Corp a Good Stock to Buy?
Determining whether Orthopediatrics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KIDS quote. (ISIN: US68752L1008)
15.20
+0.14(+0.93%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.54
15.79
52 wk Range
14.42
23.70
KIDS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.5415.79
52 wk Range
14.4223.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
KIDS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
25.00
Upside
+64.47%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- Form 8K Orthopediatrics Corp For: 1 April
- Investing.com
- Form 144 ORTHOPEDIATRICS CORP For: 16 March
- Investing.com
- OrthoPediatrics receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 25.00
(+64.47% Upside)
Orthopediatrics Corp SWOT Analysis
Pediatric Orthopedics | OrthoPediatrics Corp. dominates the niche pediatric orthopedic market, leveraging specialized focus to drive impressive growth and expand market presence |
Financial Momentum | Explore OrthoPediatrics' robust financial performance, with Q3 2024 revenue surpassing estimates and full-year guidance raised to $202-$204 million |
Strategic Expansion | Delve into the company's ambitious clinic network expansion plans, aiming to open 18 new markets by 2027 and strengthen its market position |
Future Projections | Analysts project revenue to reach $242-$244 million by 2025, with improving profitability and a target price of $50 set by JMP Securities |
Orthopediatrics Corp Earnings Call Summary for Q1/2026
- OrthoPediatrics Q1 2026 EPS of -$0.45 beat forecast of -$0.48; revenue of $59.4M exceeded expectations by 1.82%
- Revenue grew 13% YoY with U.S. up 11% and international surging 22%; adjusted EBITDA improved to $2.2M from -$0.4M loss
- Company raised full-year 2026 revenue guidance to $263-$267M, projecting 11%-13% growth driven by product launches
- Stock rose 2.53% aftermarket to $14.64; analysts maintain bullish outlook with price targets ranging from $20-$34
- Gross margin held steady at 73%; executives cite strategic initiatives and innovation pipeline as key growth drivers
Last Updated: 2026/04/30, 23:56
Read Full TranscriptEarnings
Latest Release
Apr 30, 2026
EPS / Forecast
-0,45 / -0,48
Revenue / Forecast
59,4M / 58,34M
Compare KIDS to Peers and Sector
Metrics to compare | KIDS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKIDSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.0x | 18.3x | −0.5x | |
PEG Ratio | 3.14 | 0.05 | 0.00 | |
Price/Book | 1.1x | 4.0x | 2.6x | |
Price / LTM Sales | 1.7x | 3.5x | 3.2x | |
Upside (Analyst Target) | 62.2% | 26.2% | 48.8% | |
Fair Value Upside | Unlock | 19.1% | 6.9% | Unlock |
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Orthopediatrics (KIDS) Stock Price Today?
The Orthopediatrics stock price today is 15,20 USD.
What Stock Exchange Does Orthopediatrics Trade On?
Orthopediatrics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Orthopediatrics?
The stock symbol for Orthopediatrics is "KIDS."
What Is the Orthopediatrics Market Cap?
As of today, Orthopediatrics market cap is 390,69M USD.
What Is Orthopediatrics's Earnings Per Share (TTM)?
The Orthopediatrics EPS (TTM) is -1,69.
When Is the Next Orthopediatrics Earnings Date?
Orthopediatrics will release its next earnings report on Aug 05, 2026.
From a Technical Analysis Perspective, Is KIDS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Orthopediatrics Stock Split?
Orthopediatrics has split 0 times.
How Many Employees Does Orthopediatrics Have?
Orthopediatrics has 602 employees.
What is the current trading status of Orthopediatrics (KIDS)?
As of May 01, 2026, Orthopediatrics (KIDS) is trading at a price of 15,20 USD, with a previous close of 15,06 USD. The stock has fluctuated within a day range of 14,54 USD to 15,79 USD, while its 52-week range spans from 14,42 USD to 23,70 USD.
What Is Orthopediatrics (KIDS) Price Target According to Analysts?
The average 12-month price target for Orthopediatrics is 25,00 USD, with a high estimate of 34 USD and a low estimate of 20 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +64,47% Upside potential.
What Is the KIDS Premarket Price?
KIDS's last pre-market stock price is 15,73 USD. The pre-market share volume is 260,00, and the stock has decreased by 0,67, or 4,45%.
What Is the KIDS After Hours Price?
KIDS's last after hours stock price is 15,56 USD, the stock has decreased by 0,50, or 3,32%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.